Stoke Therapeutics (STOK) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Stoke Therapeutics (STOK) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Stoke Therapeutics

· STOK

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

1.674 B

+1.29%

General

Market Cap: $1.65B
Enterprise Value: $1.55B
Shares Outstanding: 62,280,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 84.67%
Operating Margin: -809.69%
Net Profit Margin: -753.60%
FCF Margin: -654.92%
ROA: -52.77%
ROE: -59.36%
ROIC: -62.74%
Current Ratio: 7.69
Debt-to-Equity: 0.01
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: 60.04
P/FCF: —
P/B: 4.79
EV/EBITDA: -7.54

Growth

Rev 1Y: 404.50%
Rev 1Y Fwd Est: -82.63%
Rev 3Y (CAGR): 145.89%
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR)

Income Statement (TTM)

Revenue: $27.59M
Gross Margin: 84.67%
Operating Expenses: $246.74M
Operating Income: -$223.38M
Net Profit: -$207.9M

Balance Sheet

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $110M
Working Capital: $280.61M
Total Assets: $393.97M
Net Debt: -$107.32M
Total Liabilities: $48.42M
Total Equity: $345.55M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$177.99M
Cash Flow from Investing: $7.75M
Cash Flow from Financing: $181.7M
Free Cash Flow: -$180.68M
Capital Expenditures: $2.69M